Previous 10 | Next 10 |
HAIFA, Israel, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological products, today issued an update to its shareholders from its Chief Executive Officer and Presid...
Without education, we are in a horrible and deadly danger of taking educated people seriously .”― G.K. Chesterton Today, we look at a name that has seen some beneficial owner buying and comes up in comments from time to time. It has been in the news this summer because o...
Moxian (NASDAQ: MOXC ) +52% on merger with Btab . More news on: Moxian, Inc., VBI Vaccines Inc., ZAGG Inc, Stocks on the move, , Read more ...
The FDA has cleared Pluristem Therapeutics' (NASDAQ: PSTI ) Expanded Access Program (EAP) for the use of its PLX-PAD cells to treat Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19 outside of the Company’s Phase II COVID-19 study in the U.S. More news on: Plu...
HAIFA, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today that the U.S. Food and Drug Administration (FDA) has cleare...
Pluristem Therapeutics (NASDAQ: PSTI ) announces the full enrollment of 20 subjects in a Phase 1 clinical trial evaluating cell therapy PLX-R18 for the potential treatment for incomplete hematopoietic recovery following hematopoietic cell transplantation, an Orphan Drug-tagged indicati...
HAIFA, Israel, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today it has completed patient enrollment in its Phase I study ev...
CureVac (NASDAQ: CVAC ) +47% on making reasonable profit on COVID-19 vaccine. More news on: CureVac N.V., LMP Automotive Holdings, Inc., Microbot Medical Inc., Stocks on the move, , Read more ...
Pluristem Therapeutics (NASDAQ: PSTI ) has signed a non-binding Memorandum of Understanding (MOU) with the UAE-based healthcare center Abu Dhabi Stem Cells Center (ADSCC). More news on: Pluristem Therapeutics Inc., Healthcare stocks news, Stocks on the move, Read more ...
HAIFA, Israel, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today its subsidiary, Pluristem Ltd., has signed a non-binding Me...
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...